Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Oct;2(5):159-164.
doi: 10.4088/pcc.v02n0502.

Methylphenidate Abuse and Psychiatric Side Effects

Affiliations

Methylphenidate Abuse and Psychiatric Side Effects

W Alexander Morton et al. Prim Care Companion J Clin Psychiatry. 2000 Oct.

Abstract

Methylphenidate is a central nervous system stimulant drug that has become the primary drug of choice in treating attention-deficit/hyperactivity disorder in children. Side effects are usually mild and are generally well tolerated by patients. Along with increases in prescribing frequency, the potential for abuse has increased. Intranasal abuse produces effects rapidly that are similar to the effects of cocaine in both onset and type. The clinical picture of stimulant abuse produces a wide array of psychiatric symptoms. There is little in the literature to differentiate methylphenidate from other stimulants when they are abused. The need for education of all involved with the use of methylphenidate is discussed to help prevent an increasing pattern of methylphenidate abuse.

PubMed Disclaimer

References

    1. Challman TD, Lipsky JJ. Methylphenidate: its pharmacology and uses. Mayo Clin Proc. 2000;75:711–721. - PubMed
    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition. Washington, DC: American Psychiatric Association. 1994
    1. Sharma V, Newcorn JH, Matier-Sharman K, and et al. Attention deficit and disruptive behavior disorders. In: Tasman A, Kay J, Lieberman JA, eds. Psychiatry. Philadelphia, Pa: Saunders. 1997 669
    1. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD) NIH Consens Statement Nov 16–18. 1998;16:1–37. - PubMed
    1. Biederman J. Attention-deficit/hyperactivity disorder: a life-span perspective. J Clin Psychiatry. 1998;59(suppl 7):4–16. - PubMed